Changes in gene expression and cellular architecture in an ovarian cancer progression model.
about
Expression and functions of galectin-7 in ovarian cancer.Regulation of cytoskeleton organization by sphingosine in a mouse cell model of progressive ovarian cancer.Biomechanical profile of cancer stem-like/tumor-initiating cells derived from a progressive ovarian cancer model.Evaluation of a nonlinear Hertzian-based model reveals prostate cancer cells respond differently to force than normal prostate cells.Ovarian tumor-initiating cells display a flexible metabolismProteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.Screening of feature genes of the ovarian cancer epithelia with DNA microarrayAn mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.Dielectrophoretic differentiation of mouse ovarian surface epithelial cells, macrophages, and fibroblasts using contactless dielectrophoresis.Dysregulation of mitotic machinery genes precedes genome instability during spontaneous pre-malignant transformation of mouse ovarian surface epithelial cells.Interleukin-12 Immunomodulation Delays the Onset of Lethal Peritoneal Disease of Ovarian Cancer.Investigating dielectric properties of different stages of syngeneic murine ovarian cancer cells.An integrated multidisciplinary model describing initiation of cancer and the Warburg hypothesis.Metabolic changes during ovarian cancer progression as targets for sphingosine treatment.Sphingolipid metabolites modulate dielectric characteristics of cells in a mouse ovarian cancer progression model.Inverse relationship between TCTP/RhoA and p53 /cyclin A/actin expression in ovarian cancer cells.Tumour-suppressor microRNAs regulate ovarian cancer cell physical properties and invasive behaviour.Bioactive sphingolipid metabolites modulate ovarian cancer cell structural mechanics.Chromosomal instability and transcriptome dynamics in cancer.Ovarian cancer evolution through stochastic genome alterations: defining the genomic role in ovarian cancer.A feasibility study for enrichment of highly aggressive cancer subpopulations by their biophysical properties via dielectrophoresis enhanced with synergistic fluid flow.Enhanced contactless dielectrophoresis enrichment and isolation platform via cell-scale microstructures.Actin filaments play a primary role for structural integrity and viscoelastic response in cells.High-frequency irreversible electroporation targets resilient tumor-initiating cells in ovarian cancer.Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells.Fluid shear stress impacts ovarian cancer cell viability, subcellular organization, and promotes genomic instability.BRAF and AXL oncogenes drive RIPK3 expression loss in cancer
P2860
Q30594259-4D271E7C-E31D-4ADB-82DD-C453CAA292FBQ33649759-A8AB4D1D-93C3-4351-833D-A1D6530A1984Q33831524-A6C590FD-D61D-42E5-9070-BF8565604557Q34446487-66FB3BBE-3409-4A85-A28D-D62A35FE827BQ34658326-AF967A34-EE0C-4A72-9AF9-AA1800AEDBBFQ34669870-75C094D6-DA4D-44AD-B266-B1EF633AF816Q34759643-122B9974-66A7-49D7-BF28-5A7CEA070412Q35109003-A362F92D-99CB-4506-9B52-DE077F0C5200Q35768429-9981F156-CB44-4849-B81D-5DCAD7AFE18CQ35837949-EA6BE57D-A414-430F-A3B7-79BEF48E90CCQ35903105-65B61965-E602-4906-8736-E266FB177648Q36179026-B9B7154B-129D-4084-B71F-3EF0239A963DQ36489567-31FB290A-0807-4454-97C5-E9ECE2249724Q36597413-2FE32BF9-A283-4DB1-9A24-99EEB365E706Q36945512-4115A2F7-9A36-4B4E-A577-8021EA420EA8Q36953297-F5F69547-3A27-4C2B-9FE8-F828FD461896Q36991426-7825E928-A8E6-4931-8ED2-FE356F545126Q37120421-77DFEB54-685F-4D35-ACDB-90FE718DB7D1Q37464162-412CDF94-A10D-42BB-9142-79DAF43650F1Q37537694-D33B210F-E62A-4F76-9F7E-C998F12B293FQ38099764-169196EE-EB18-45FB-A4B9-8AA7BAF7CDFDQ38154665-A7F49388-D011-4803-99E8-30D366BAF037Q38710576-D7A9386B-507E-44D8-B1FD-FE35BFEDAD2BQ38795499-3383A8C1-CDF1-49B2-978C-2666B650E120Q39374361-B2ACDAB2-2972-4BE5-8337-37F09E0B4F79Q45074250-ACAA0544-F26A-4153-A10E-CCF978BF246DQ46277468-198A1BA9-FA2E-4AD9-AE36-2BE32ED0DD75Q55339618-52AE845A-BBA9-475C-A957-8D3FB3531D32Q58696646-F16F7A37-E493-4BE0-95D8-504B55FE5C89
P2860
Changes in gene expression and cellular architecture in an ovarian cancer progression model.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Changes in gene expression and ...... rian cancer progression model.
@ast
Changes in gene expression and ...... rian cancer progression model.
@en
type
label
Changes in gene expression and ...... rian cancer progression model.
@ast
Changes in gene expression and ...... rian cancer progression model.
@en
prefLabel
Changes in gene expression and ...... rian cancer progression model.
@ast
Changes in gene expression and ...... rian cancer progression model.
@en
P2093
P2860
P1433
P1476
Changes in gene expression and ...... rian cancer progression model.
@en
P2093
Eva M Schmelz
Paul C Roberts
Roderick V Jensen
William T Silkworth
P2860
P304
P356
10.1371/JOURNAL.PONE.0017676
P407
P577
2011-03-03T00:00:00Z